Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
5 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Summit Therapeutics Inc.’s names, not what it holds today.
Patents granted
5
5 utility, 1976 to Dec 31, 2025
Granted in 2025
1
in the last year the record reads
Applications published
15
1 of them in 2025
Names they are printed under
4
a subsidiary
By yearGrantedApplications published
'14'16'17'18'19'20'21'22'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Organic fine chemistry1
Computer technology1
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
DISCUVA LIMITED a subsidiary
GB, as the owner printed on each patent
10 publishedDISCUVA LIMITED a subsidiary
named as the applicant on its applications, in GB
3 publishedSummit (Oxford) Limited a subsidiary
named as the applicant on its applications, in GB
2 publishedSUMMIT (OXFORD) LIMITED a subsidiary
GB, as the owner printed on each patent
0 publishedNames not counted (5)
Summit Corp plc
Most of its patents print GB; this name counts in US. 6 granted and 9 published under it are not counted.
Summit Corp plc
Most of its patents print GB; this name counts in US. 0 granted and 8 published under it are not counted.
Summit Therapeutics Inc.
Most of its patents print GB; this name counts in US. 3 granted and 2 published under it are not counted.
Summit Therapeutics Inc.
Most of its patents print GB; this name counts in US. 0 granted and 3 published under it are not counted.
Summit Licensing Company
PatentsView's organization Summit Licensing Company is another company: its one patent prints New York, New York and covers a walking toy (Walking toy, granted Apr 7, 1981). Summit Therapeutics Inc. files from Florida, and nothing in its record ties it to this owner, whose name only adds a patent-holding word to the company's.. 1 granted and 0 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jun 3, 2025 | 12,318,487 | Solid tablet dosage form of ridinilazole | Pharmaceuticals | SUMMIT (OXFORD) LIMITED |
| Jun 14, 2022 | 11,359,195 | Method for identifying antibiotic targets | Computer technology | DISCUVA LIMITED |
| May 31, 2022 | 11,345,694 | Antibacterial compounds | Organic fine chemistry | DISCUVA LIMITED |
| Aug 29, 2017 | 9,745,572 | Method for identifying antibiotic targets | Computer technology | DISCUVA LIMITED |
| Nov 15, 2016 | 9,493,770 | Method for identifying antibiotic targets by complemented sequencing | Computer technology | DISCUVA LIMITED |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Sep 4, 2025 | 2025/0276965 | PROCESS FOR THE PREPARATION OF ANTIBACTERIAL COMPOUNDS | Pharmaceuticals | DISCUVA LIMITED |
| Jul 11, 2024 | 2024/0228474 | ANTIBACTERIAL COMPOUND | Pharmaceuticals | DISCUVA LIMITED |
| Nov 24, 2022 | 2022/0372027 | ANTIBACTERIAL COMPOUNDS | Organic fine chemistry | DISCUVA LIMITED |
| Sep 15, 2022 | 2022/0289705 | PROCESS FOR THE PREPARATION OF RIDINILAZOLE AND CRYSTALLINE FORMS THEREOF | Organic fine chemistry | Summit (Oxford) Limited |
| Jun 16, 2022 | 2022/0186211 | METHOD FOR IDENTIFYING ANTIBIOTIC TARGETS | Computer technology | DISCUVA LIMITED · patent 11,359,195 granted from it |
| Jun 3, 2021 | 2021/0163460 | ANTIBACTERIAL COMPOUNDS | Organic fine chemistry | DISCUVA LIMITED · patent 11,345,694 granted from it |
| Jan 16, 2020 | 2020/0016076 | COMPOSITION FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | Pharmaceuticals | Summit (Oxford) Limited |
| Jun 27, 2019 | 2019/0194179 | ANTIBIOTIC COMPOUNDS | Organic fine chemistry | DISCUVA LIMITED |
| Jun 28, 2018 | 2018/0179518 | IDENTIFYING GENES INVOLVED IN ANTIBIOTIC RESISTANCE AND SENSITIVITY IN BACTERIA USING MICROCULTURES | Biotechnology | DISCUVA LIMITED |
| Jan 11, 2018 | 2018/0010122 | METHOD FOR IDENTIFYING ANTIBIOTIC TARGETS | Computer technology | DISCUVA LIMITED · patent 11,359,195 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 2.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.